Format

Send to

Choose Destination
See comment in PubMed Commons below
J Pediatr Hematol Oncol. 2013 Jan;35(1):e42-6. doi: 10.1097/MPH.0b013e318279aed8.

Prolonged survival after treatment of diffuse intrinsic pontine glioma with radiation, temozolamide, and bevacizumab: report of 2 cases.

Author information

1
Aflac Center for Cancer and Blood Disorders Service, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA 30322, USA.

Abstract

BACKGROUND:

Diffuse intrinsic pontine gliomas have poor prognosis.

OBSERVATION:

We report on 2 patients with diffuse intrinsic pontine glioma treated with radiation, followed by temozolamide 200 mg/m/d for 5 days every 28 days and bevacizumab 10 mg/kg/dose every 14 days. Both patients have ongoing PFS of 37 and 47 months from diagnosis. A decrease in tumor size by >65% was observed in both the patients. Both patients continue treatment. No steroid requirement since 10 weeks after radiation. Quality of life is excellent and the chemotherapy regimen is well tolerated.

CONCLUSIONS:

A clinical trial in an expanded cohort is warranted to determine the toxicity and evaluate response.

PMID:
23249962
DOI:
10.1097/MPH.0b013e318279aed8
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Support Center